Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice

American Journal of Pathology

Volumn 176, Issue 5, 2010, Pages 2456-2466

  Li, Jiaping ^a   Ramani, Komal ^a   Sun, Zhanfeng ^a   Zee, Chishing ^a   Grant, Edward G ^a   Yang, Heping ^a   Xia, Meng ^a   Oh, Pilsoo ^a   Ko, Kwangsuk ^a   Mato, José M ^b   Lu, Shelly C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD31 ANTIGEN; KI 67 ANTIGEN; METHIONINE ADENOSYLTRANSFERASE; METHIONINE ADENOSYLTRANSFERASE 1A; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH RATE; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING;

EID: 77952060817     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090810     Document Type: Article

References (36)

1. Mato JM, Lu SC: Role of S-adenosyl-L-methionine in liver health and injury. Hepatology 2007, 45:1306-1312 (Pubitemid 46775795)
2. Kotb M, Mudd SH, Mato JM, Geller AM, Kredich NM, Chou JY, Cantoni GL: Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet 1997, 13:51-62
3. Gil B, Casado M, Pajares MA, Boscá L, Mato JM, Martín-Sanz P, Alvarez L: Differential expression pattern of SAM synthetase isoenzymes during rat liver development. Hepatology 1996, 24:876-881 (Pubitemid 26334288)
4. Huang ZZ, Mao Z, Cai J, Lu SC: Changes in methionine adenosyltransferase during liver regeneration in the rat. Am J Physiol 1998, 275:G14-G21
5. Huang ZZ, Mato JM, Kanel G, Lu SC: Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression. Hepatology 1999, 29:1471-1478 (Pubitemid 29211049)
6. Cai J, Sun WM, Hwang J, Stain S, Lu SC: Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance. Hepatology 1996, 24:1090-1097 (Pubitemid 26365909)
7. Cai J, Mao Z, Hwang JJ, Lu SC: Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res 1998, 58:1444-1450 (Pubitemid 28193606)
8. Mato JM, Corrales FJ, Lu SC, Avila MA: S-adenosylmethionine: a control switch that regulates liver function. FASEB J 2002, 16:15-26
9. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden. Globocan 2000. Int J Cancer 2001, 94:153-156
10. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-390
11. Sypsa V, Touloumi G, Papatheodoridis GV, Tassopoulos NC, Ketikoglou I, Vafiadis I, Hatzis G, Tsantoulas D, Akriviadis E, Koutsounas S, Hatzakis A: Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. J Viral Hep 2005, 12:543-550
12. Lu SC, Ramani K, Ou XP, Lin M, Yu V, Ko K, Park R, Bottiglieri T, Tsukamoto H, Kanel G, French S, Mato JM, Moat R, Grant E: S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model. Hepatology 2009, 50:462-471
13. Yang HP, Sadda MR, Li M, Zeng Y, Chen LX, Bae WJ, Ou X, Runnegar MT, Mato JM, Lu SC: S-Adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: role of protein phosphatase 1 and Bcl-xS. Hepatology 2004, 40:221-231
14. Yang HP, Iglesias Ara A, Magilnick N, Xia M, Ramani K, Chen H, Lee TD, Mato JM, Lu SC: Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in hepatoma cells. Gastroenterology 2008, 134:281-291
15. Weidner N, Semple JP, Welch WR, Folkman J: Tumour angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
16. Farrar C, Clarke S: Altered levels of S-adenosylmethionine and S-adenosylhomocysteine in the brains of L-isoaspartyl (D-aspartyl) O-methyltransferase- deficient mice. J Biol Chem 2002, 277:27856-27863 (Pubitemid 34966731)
17. Ramani K, Yang HP, Xia M, Iglesias Ara A, Mato JM, Lu SC: Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2β. Hepatology 2008, 47:521-531 (Pubitemid 351280720)
18. Zhao J, Dong L, Lu B, Wu G, Xu D, Chen J, Li K, Tong X, Dai J, Yao S, Wu M, Guo Y: Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology 2008, 135:956-968
19. Rangaswami H, Bulbule A, Kundu GC: Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006, 16:79-87 (Pubitemid 43247403)
20. Millward TA, Zolnierowicz S, Hemmings BA: Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999, 24:186-191 (Pubitemid 29348452)
21. Huynh H, Soo KC, Chow P, Tran E: Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma. Mol Cancer Ther 2007, 6:138-146 (Pubitemid 46206676)
22. Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S: Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 2005, 103:307-312 (Pubitemid 40129290)
23. Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE: Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi. China Cancer Res 1989, 49:2506-2509 (Pubitemid 19125586)
24. Torres L, Avila MA, Carretero MV, Latasa MU, Caballeria J, López- Rodas G, Boukaba A, Lu SC, Franco L, Mato JM: Liver-specific methionine adenosyltransferase MAT1A gene expression is associated to a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation. FASEB J 2000, 14:95-102
25. Chen L, Zeng Y, Yang HP, Lee TD, French SW, Corrales FJ, García- Trevijano ER, Avila MA, Mato JM, Lu SC: Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. FASEB J 2004, 18:914-916
26. Martínez-Chantar ML, Corrales FJ, Martínez-Cruz LA, García-Trevijano ER, Huang ZZ, Chen L, Kanel G, Avila MA, Mato JM, Lu SC: Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J 2002, 16:1292-1294
27. Martínez-Chantar ML, Vázquez-Chantada M, Garnacho M, Latasa MU, Varela-Rey M, Dotor J, Santamaria M, Martínez-Cruz LA, Parada LA, Lu SC, Mato JM: S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase. Gastroenterology 2006, 131:223-232
28. Vázquez-Chantada M, Ariz U, Varela-Rey M, Embade N, Martínez- Lopez N, Fernández-Ramos D, Gómez-Santos L, Lamas S, Lu SC, Martínez-Chantar ML, Mato JM: Evidence for an LKB1/AMPK/eNOS cascade regulated by HGF, S-adenosylmethionine, and NO in hepatocyte proliferation. Hepatology 2009, 49:608-617
29. Ansorena E, García-Trevijano ER, Martínez-Chantar ML, Huang ZZ, Chen LX, Mato JM, Iraburu M, Lu SC, Avila MA: S-adenosylmethionine and methylthioadenosine are anti-apoptotic in cultured rat hepatocytes but pro-apoptotic in human hepatoma cells. Hepatology 2002, 35:274-280
30. Li T, Zhang Q, Oh P, Xia M, Chen H, Bemanian S, Lastra N, Circ M, Moyer MP, Mato JM, Aw TY, Lu SC: S-adenosylmethionine and methylthioadenosine inhibit cellular FLICE inhibitory protein expression and induce apoptosis in colon cancer cells. Mol Pharmacol 2009, 76:192-200
31. Clarke SG: Inhibition of mammalian protein methyltransferases by 5′-methylthioadenosine (MTA): a mechanism of action of dietary SAMe? The Enzymes 2006, 24:467-493
32. Chen GH, Lai P, Chak E, Xu H, Lee KM, Lau WY: Immunohistochemical analysis of pro-apoptotic Bid levels in chronic hepatitis, hepatocellular carcinoma and liver metastases. Cancer Lett 2001, 172:75-82 (Pubitemid 32823475)
33. Huang J, Lin Y, Li L, Qing D, Teng X, Zhang Y, Hu H, Hu Y, Yang P, Han Z: ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis. Molecular Carcinogenesis 2009, 48:130-140
34. Huang J, Zhang Y, Teng X, Lin Y, Zheng D, Yang P, Han Z: Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma. BMC Cancer, 7:126
35. Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe FR, Hoang BH: Expression of frzb/secreted frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res 2005, 65:9762-9770 (Pubitemid 41541453)
36. Calvisi DF, Simile MM, Ladu S, Pellegrino R, DeMurtas V, Pinna F, Tomasi ML, Frau M, Virdis P, De Miglio MR, Muroni MR, Pascale RM, Feo F: Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. Int J Cancer 2007, 121:2410-2420